Dr Jaroslav Boublik initially trained as an endocrine receptor biologist and peptide chemist. In the early 1990s, Dr Boublik made a shift into nutritional medicine, initially with a focus on human hydration research, and later more broadly in nutritional supplement research and development. Most recently he has shifted focus again to two areas of therapeutics set to disrupt current medical practice – cannabinoids and probiotics. Dr Boublik sits on the board of several leading companies in the nutritional and complementary medicine industry.

Director & Chief Science Officer/Biome Australia Ltd

JAROSLAV BOUBLIK

Session:

CLINICAL PHARMACY UPDATE: The potential of probiotics for the management of paediatric asthma

When:

Saturday 21 March, 11:55pm-12:25pm

Proudly sponsored by:

SESSION SPONSORS

PROGRAM SPONSORS

MAJOR SPONSORS

PRINCIPAL SPONSORS

APP2020 SPONSORS

SESSION SPONSOR

PROGRAM SPONSOR

MAJOR SPONSOR

VIEW ALL

PRINCIPAL SPONSOR

APP2020 SPONSORS

Alternate Arrow Circle UpFont Awesome Free 5.0.6 by @fontawesome - http://fontawesome.com License - http://fontawesome.com/license (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License)

NEWSLETTER

Join the conversation #APP2020

Events Division - The Pharmacy Guild of Australia, Queensland Branch

CONNECT

132 Leichhardt St, Spring Hill QLD 4000

07 3831 9246

SITE CREDITS

CONTACT US

© 2020 APP Conference 2020. All Rights Reserved.

The 2020 Australian Pharmacy Professional Conference is proudly sponsored by: